Welcome to Ostia Sciences, a premier microbiome solutions company that specializes in discovering novel bacterial metabolites with antibacterial, antibiofilm, and immunomodulation activities. Our goal is to isolate beneficial microbes from the human oral microbiome, human breast milk, and fermented food, which are known to be rich sources of ribosomally synthesized and post-translationally modified peptides (RiPPs) and natural products with a range of biological activities.
| Website | https://www.ostiasciences.ca/ |
| Employees | 12 (8 on RocketReach) |
| Founded | 2020 |
| Phone | +1 647-643-7547 |
| Industry | Biotechnology Research |
| Keywords | Antibacterial Agents, Immunomodulation, Beneficial Microbes, Novel Therapeutics, Drug Discovery, Biotechnology, Pharmaceutical Research, Life Sciences, Preclinical Research, Microbiome Research, Microbial Identification, Infection Control, Gut Microbiome, Scientific Research, Bioactive Compounds |
| Competitors | CRISPR Therapeutics, Editas Medicine, Intellia Therapeutics, Inc., Sangamo Therapeutics, Inc., Zymeworks Inc., Zymergen, Inc., Amgen, Biogen, Regeneron, Moderna Therapeutics +48 more (view full list) |
Looking for a particular Ostia Sciences Inc. employee's phone or email?
Abdelahhad Barbour is the CEO and Co-Founder of Ostia Sciences Inc..
8 people are employed at Ostia Sciences Inc..
Ostia Sciences Inc. is based in Toronto, Ontario.